Oncology Knowledge into Practice

Free, independent education to support healthcare professionals in oncology. Our interactive resources are localised, translated and CME-accredited. Join today!

[Oncology Knowledge into Practice @OncKIP]

November is Lung Cancer Awareness Month 2022.
#LungCancer causes more deaths globally than #colon, #breast, & #prostate cancers combined (Ref @IASLC)
Knowledge gives us the power to fight that; try this free accredited workshop https://t.co/VuRxKo5yLE
#LCSM #LCAM22 #CMECPD

[Oncology Knowledge into Practice @OncKIP]

Classroom to Clinic™: Optimizing biomarker-driven therapy in #NSCLC.
With Prof. Fernando Lopez-Rios & Prof. Jessica Lin

Take the hard work out of preparing your next #grandrounds with this free #accredited module
https://t.co/yTf8kJeZQs

#oncology #CMECPD #biomarkers #thoracic

[Oncology Knowledge into Practice @OncKIP]

Classroom to Clinic™: Optimizing biomarker-driven therapy in #NSCLC.
With Prof. Fernando Lopez-Rios & Prof. Jessica Lin

Take the hard work out of preparing your next #grandrounds with this free #accredited module
https://t.co/yTf8kJeZQs

#oncology #CMECPD #biomarkers #thoracic

[Oncology Knowledge into Practice @OncKIP]

Classroom to Clinic™ is a complete and free peer-to-peer #teaching package; it provides all the content and activity plans you need to facilitate an #accredited group session.
Discover the latest #NSCLC module available now https://t.co/yTf8kJw2Ss

#oncology #CMECPD #BIOMARKERS

[Oncology Knowledge into Practice @OncKIP]

Looking forward to hearing outcomes from the phase 3 CodeBreak 200 study investigating sotorasib vs. docetaxel for KRAS G12C mutant advanced NSCLC tomorrow! #ESMO22

[Julien Mazieres @JulienMazieres]

❗️Many drugs targeting KRAS are currently tested. Among which 4 are tested in phase 3 trial (vs docetaxel). ⚠️CodeBreaK 200 to be released on Monday #ESMO22. Great overview by ⁦@Tony_Calles⁩ ⁦@OncoAlert⁩

[Manuel Dómine, MD, PhD @ManuelDomine]

KEYNOTE-189: 5-Y Update: The study that changed the standard treatment of metastatic nsqNSCLC.5-y OS: 19.4% vs 11.3%,5-y PFS: 7.5% vs 0.6%. 72% of pts who completed 35 cycles of pembrolizumab were alive 3 y after completion of 35 cycles @Hospital_FJD @OncoAlert @myESMO #LCSM

[Oncology Knowledge into Practice @OncKIP]

An inspiring talk reminding us to continue to strive for equality

[Mariana Brandao @MarianaBrandao0]

Beautiful talk by Dr Fátima Cardoso while receiving the @myESMO Women for Oncology Award 2022 🙏
We should actively work to end the #gendergap & to improve women's rights around the world. We should #speakup & maybe do some conscious bias from time to time :)
@OncoAlert #ESMO22

[ESMO - Eur. Oncology @myESMO]

#ESMO22 Highlights on MONARCH 3: Interim overall survival results of abemaciclib plus a nonsteroidal aromatase inhibitor in patients with HR+, #HER2- #advancedbreastcancer by Matthew Goetz.
https://t.co/nOdNbFqFx5
#bcsm

[Oncology Knowledge into Practice @OncKIP]

Another fantastic day at #ESMO22

[ESMO - Eur. Oncology @myESMO]

#ESMO22 Day 2 agenda: Proffered Paper sessions, Multidisciplinary & Special sessions, Mini Orals, Challenge your Expert, sessions for #youngoncologists & #patientadvocates, &, la pièce de résistance, the Presidential Symposium I (16:30 - Paris Auditorium) https://t.co/iqigoQq2vi

[Oncology Knowledge into Practice @OncKIP]

We're looking forward to some excellent sessions at #ESMO22.
We'd also be delighted to chat about our free, independent education; message us if you'd like to meet up! 9th - 13th Sept #Paris Expo Porte de Versailles.

https://t.co/NRuHMPcKEu
#ONCOLOGY #CMECPD #MEDICALEDUCATION

[Oncology Knowledge into Practice @OncKIP]

Take a look at our collection of free, pre-designed Classroom to Clinic™ modules.
These complete educational packages are ready for you to tailor to your group's learning needs and time available.
https://t.co/fwaWh8GzTy
#Cancers #Biomarkers #NSCLC #BreastCancer #oncology #CPD

[Liberum IME @LiberumIME]

Classroom to Clinic ™ puts pre-designed #accredited education into the hands of busy #Healthcare Professionals, making it easier than ever to facilitate group #learning and share knowledge.

Find out more https://t.co/9WwjqePeCh

#cmecpd #medicaleducation #hcpengagement

[Oncology Knowledge into Practice @OncKIP]

Thank you to all that attended todays symposium!

For those who missed it, not to worry. This Classroom to Clinic™ module on #biomarker-driven therapy in #NSCLC is available for free on our website. Visit https://t.co/0XaSYu1C6H to find out more

#WCLC22 #WCLC2022 #lungcancer

[Oncology Knowledge into Practice @OncKIP]

Great turn out for today’s symposium @IASLC congress “Optimizing biomarker-driven therapy in NSCLC: Classroom to Clinic™”

Prof. López-Ríos and Dr Cornelissen are now closing the session with a Q&A.

Watch this space for further updates on this module.
#WCLC22 #LCSM #lungcancer

[Oncology Knowledge into Practice @OncKIP]

Time to come join us at Hall C1 to grab your refreshments and join us for our symposium on "Optimizing biomarker-driven therapy in NSCLC: Classroom to Clinic™"

@IASLC #LCSM #lungcancer #BiomarkerTesting

[Oncology Knowledge into Practice @OncKIP]

1 hour to go…

Meet us outside Hall C1 to grab your refreshments and join us for our symposium on "Optimizing biomarker-driven therapy in NSCLC: Classroom to Clinic™"

For more information, visit https://t.co/412EMpN5a5

@IASLC
#WCLC22 #LCSM #lungcancer #BiomarkerTesting

[Oncology Knowledge into Practice @OncKIP]

24 hours to go!
See the agenda for tomorrow's symposium: Optimizing biomarker-driven therapy in NSCLC: Classroom to Clinic

Join us at the @IASLC #WCLC22 conference 14:30-15:30 CEST in Hall C1
Refreshments will be provided.
Find out more https://t.co/UxjNseLxa6
#LCSM #lungcancer

[Oncology Knowledge into Practice @OncKIP]

We're looking forward to presenting Classroom to Clinic as part of our interactive #NSCLC symposium tomorrow. Don’t miss out on obtaining this truly innovative tool!
If you're attending @IASLC #WCLC22 please join us: 14:30 CEST Hall C1.

[Oncology Knowledge into Practice @OncKIP]

Join us for our interactive symposium at the @IASLC #WCLC22 congress on 6 August for an overview of the integration of #BiomarkerTesting strategies and associated treatment decision making in #NSCLC.

Chaired by Prof. López-Ríos and joined by guest speaker Dr Cornelissen

[Oncology Knowledge into Practice @OncKIP]

Join us for our interactive symposium at the @IASLC #WCLC22 congress on 6 August for an overview of the integration of #BiomarkerTesting strategies and associated treatment decision making in #NSCLC.

Chaired by Prof. López-Ríos and joined by guest speaker Dr Cornelissen

[Oncology Knowledge into Practice @OncKIP]

We're excited to be hosting a symposium at this year's @IASLC #WCLC22 congress: "Optimising biomarker-driven therapy in NSCLC: Classroom to Clinic™"

Join us for the latest insights in this area from Prof. Lopez-Rios and Dr Cornelissen

Find out more - https://t.co/412EMpN5a5

[Oncology Knowledge into Practice @OncKIP]

Tune into this 5-minute learning mini module, where our experts cover some highlights relating to immune checkpoint inhibitors (#ICIs) from the most recent #ESMO #Immuno-Oncology Congress.

Click here to complete this module and claim 0.25 CME credits - https://t.co/fCpUjH6UtW